CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
Authors
Keywords
CIB1, TRAIL, Apoptosis, Triple-negative breast cancer, Chemoresistance
Journal
Cancer Cell International
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-04
DOI
10.1186/s12935-019-0740-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glutamine metabolism regulates FLIP expression and sensitivity to TRAIL in triple-negative breast cancer cells
- (2018) Marta Mauro-Lizcano et al. Cell Death & Disease
- Pterostilbene Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors and Downregulation of Cell Survival Proteins in TRAIL-Resistance Triple Negative Breast Cancer Cells
- (2017) Chao-Ming Hung et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Phytoagent deoxyelephantopin derivative inhibits triple negative breast cancer cell activity by inducing oxidative stress-mediated paraptosis-like cell death
- (2017) Jeng-Yuan Shiau et al. Oncotarget
- Cancer therapy in the necroptosis era
- (2016) Z Su et al. CELL DEATH AND DIFFERENTIATION
- Withaferin A Induces ROS-Mediated Paraptosis in Human Breast Cancer Cell-Lines MCF-7 and MDA-MB-231
- (2016) Kamalini Ghosh et al. PLoS One
- CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer
- (2015) Justin L. Black et al. BREAST CANCER RESEARCH AND TREATMENT
- Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer
- (2015) J.M. Nabholtz et al. INTERNATIONAL JOURNAL OF CANCER
- Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy
- (2015) Jonathan So et al. Science Signaling
- Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy
- (2015) Jonathan So et al. Science Signaling
- Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
- (2015) Rachana Trivedi et al. Frontiers in Oncology
- Endoplasmic reticulum vacuolation and unfolded protein response leading to paraptosis like cell death in cyclosporine A treated cancer cervix cells is mediated by cyclophilin B inhibition
- (2014) Babul Moni Ram et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Trypan blue exclusion assay by flow cytometry
- (2014) B.A. Avelar-Freitas et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Getting TRAIL back on track for cancer therapy
- (2014) J Lemke et al. CELL DEATH AND DIFFERENTIATION
- Topoisomerase I as a target of erlotinib and gefitinib: Efficacy of combined treatments with camptothecin
- (2014) REFAEL PELEG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Die another way – non-apoptotic mechanisms of cell death
- (2014) Stephen W. G. Tait et al. JOURNAL OF CELL SCIENCE
- TRAIL combinations: The new ‘trail’ for cancer therapy (Review)
- (2014) ALAA REFAAT et al. Oncology Letters
- Identification of plant extracts sensitizing breast cancer cells to TRAIL
- (2013) SHERIF ABDELHAMED et al. ONCOLOGY REPORTS
- ALIX and the multivesicular endosome: ALIX in Wonderland
- (2013) Christin Bissig et al. TRENDS IN CELL BIOLOGY
- Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity
- (2013) M Bury et al. Cell Death & Disease
- Multiple ways to die: Non-apoptotic forms of cell death
- (2012) Yoshihide Tsujimoto ACTA ONCOLOGICA
- Emerging targeted therapies in triple-negative breast cancer
- (2012) J. Crown et al. ANNALS OF ONCOLOGY
- Targeting triple-negative breast cancer: optimising therapeutic outcomes
- (2012) K. Gelmon et al. ANNALS OF ONCOLOGY
- CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy
- (2012) A. Kathleen McClendon et al. CELL CYCLE
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
- (2012) Lisa A. Carey et al. JOURNAL OF CLINICAL ONCOLOGY
- XIAP Inhibition and Generation of Reactive Oxygen Species Enhances TRAIL Sensitivity in Inflammatory Breast Cancer Cells
- (2012) J. L. Allensworth et al. MOLECULAR CANCER THERAPEUTICS
- CIB1 prevents nuclear GAPDH accumulation and non-apoptotic tumor cell death via AKT and ERK signaling
- (2012) T M Leisner et al. ONCOGENE
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Synergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly(ADP-Ribose) Polymerase Inhibition, Gemcitabine, and Cisplatin
- (2010) K. Hastak et al. CANCER RESEARCH
- BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane
- (2010) Z T Schug et al. CELL DEATH AND DIFFERENTIATION
- Necroptosis as an alternative form of programmed cell death
- (2010) Dana E Christofferson et al. CURRENT OPINION IN CELL BIOLOGY
- Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
- (2009) B. Corkery et al. ANNALS OF ONCOLOGY
- Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells
- (2009) Mi Jin Yoon et al. FREE RADICAL BIOLOGY AND MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now